Product Images Leuprolide Acetate Depot
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 16 images provide visual information about the product associated with Leuprolide Acetate Depot NDC 69097-909 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - leuprolide acetate injection 01
This text appears to be a list of various components and parts related to medical equipment such as syringes and vials. It includes items such as plunger, rod, backstop, syringe barrel, vial adapter, needle, flip-off button, and vial.*
Figure 2 - leuprolide acetate injection 02
Figure 3 - leuprolide acetate injection 03
figure 4 - leuprolide acetate injection 04
figure 5 - leuprolide acetate injection 05
Figure 6 - leuprolide acetate injection 06
Figure 7 - leuprolide acetate injection 07
Figure 7 - leuprolide acetate injection 08
Figure 7 - leuprolide acetate injection 09
Figure 7 - leuprolide acetate injection 10
Chemical structure of leuprolide acetate - leuprolide acetate injection 11
Figure 12 - leuprolide acetate injection 12
Figure 12 - leuprolide acetate injection 13
Label A - leuprolide acetate injection 14
Leuprolide acetate for depot suspension is a medication that requires reconstitution before being used for intramuscular injection. The recommended dose is one injection every three months. The medication is stored in a controlled room temperature between 20°C to 25°C with excursions permitted between 15°C to 30°C. The medication is manufactured by GPharm, SA and comes in a single vial containing 225g and packaged in a carton. The dosage and administration procedures can be found in the package insert.*
Label B - leuprolide acetate injection 15
This is a description of a medication in the form of a 2 mL mannitol solution for intramuscular injection. It is intended for reconstitution of Leuprolide igé acetate Depot g3 and is only available with a prescription. The solution should be stored at 20°-25°C (68°-77°F). The text also includes the size of the needle (24mm) and the fact that the solution does not contain the active substance LOQS,VBZP. The other text appears to be information regarding the packaging and labeling of the medication.*
Label C - leuprolide acetate injection 16
This is a sterile Depot suspension medication called Leuprolide Acetate Pejivers. Each suspension contains 22.5mg of Leuprolide Acetate. It is manufactured and distributed by Cipla and is available by prescription only. This medication should be stored at a temperature between 20°C-25°C (68°F-77°F).*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.